13.03.2014 Views

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Lectures<br />

TOXCAT METHOD: APPLICATION IN MOLECULar ONCOLOGY<br />

Martin Benej 1 and Martina Poturnajová 2<br />

1<br />

Department of Molecular Biology UK Bratislava,<br />

2<br />

Cancer Research Institute SAS Bratislava<br />

Understanding the molecular mechanisms of cancer onset is one of the goals of contemporary<br />

cancer research. Individual approach to each disease is of crucial importance<br />

in this issue. Moreover, not only each disease, but also each patient carrying causative<br />

mutation in his/her genome requires individual approach. Thus, a need of a whole set<br />

of methods for characterization of causative mutations has arisen. ToxCAT is a method<br />

simulating the natural lipid bilayer environment, enabling the study of transmembrane<br />

(TM) domain interactions in vitro. The method is based on introduction of chimaeric constructs<br />

containing a TM domain of interest into periplasmic region of E.coli MM39 strain.<br />

Interactions of the chimerae result in expression of chloramphenicol acetyltransferase<br />

(CAT) reporter gene. The quantity of CAT expression corresponds with the strength of TM<br />

domain association. We illustrate the ToxCAT method application on the specific model<br />

of our interest – Medullary thyroid carcinoma (MTC). MTC is caused predominantly by<br />

single point mutations in six RET proto-oncogene exons. RET protein, the product of the<br />

RET gene is a tyrosine kinase cell-surface receptor. Mutations in extracellular domain of<br />

the receptor result in dimerization of the RET protein with other mutant RET molecule,<br />

thus enabling ligand-independent permanent activation of the RET receptor kinase. For<br />

this interaction, the strength of transmembrane domain oligomerization of the two RET<br />

molecules is responsible. We focus on the impact of RET TM domain mutations of Slovak<br />

MTC patients on the strength of TM domain oligomerization, to investigate a possible<br />

correlation with the age of onset and aggressiveness of the disease.<br />

46 <strong>XXII</strong>. Biochemistry Congress, Martin

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!